Figure 5.
Figure 5. Tumor cell–specific BCR-mediated Btk, Syk, Erk1/2, and p38 signaling. Flow cytometry contour plots of FL patient biopsy cells (FL-P09) stimulated by BCR cross-linking plus H2O2 (α-μ/γ + H2O2) for 4 or 30 minutes or left unstimulated (0 minute). BCR-mediated phosphorylation of Btk, Syk, Erk1/2, and p38 was compared in FL B cells (CD20+ Bcl-2hi λ–, dark arrow) and nonmalignant B cells (CD20hi Bcl-2lo, light arrow).

Tumor cell–specific BCR-mediated Btk, Syk, Erk1/2, and p38 signaling. Flow cytometry contour plots of FL patient biopsy cells (FL-P09) stimulated by BCR cross-linking plus H2O2 (α-μ/γ + H2O2) for 4 or 30 minutes or left unstimulated (0 minute). BCR-mediated phosphorylation of Btk, Syk, Erk1/2, and p38 was compared in FL B cells (CD20+ Bcl-2hi λ, dark arrow) and nonmalignant B cells (CD20hi Bcl-2lo, light arrow).

Close Modal

or Create an Account

Close Modal
Close Modal